We identified the CDKN2A(47T>G)/p16-L16R variant in four multigeneration kindreds of Mayo Clinic patients that contained members diagnosed with familial pancreatic cancer and melanoma. This evidence concerns the gene CDKN2A and pancreatic neoplasm.